By Matt Jones

NEW YORK (GenomeWeb News) – Researchers across Canada will use C$5 million (US$4.9 million) in funding from the Terry Fox Research Institute and the Canadian Partnership Against Cancer to create a new validation system for stratifying ovarian cancer patients based on biomarkers and to predict which patients will respond to standard treatments, TFRI said Thursday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.